FDA approves new weight loss drug Zepbound

Science & Technology
Published on Nov 10, 2023
The FDA approved a new drug for obesity, Zepbound, made by Eli Lilly, which is potentially more effective at losing weight than any other drug on the market. The medication is already being sold as diabetes drug Mounjaro. NBC News’ Stephanie Gosk has more details.

» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://smart.link/5d0cd9df61b80
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=sm_npd_nn_yt_bn-clip_190621
Visit NBCNews.Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Get more of NBC News delivered to your inbox: nbcnews.com/newsletters

#FDA #WeightLoss #Medication